Effect of non-cephalosporin antibiotic prophylaxis on the risk of periprosthetic joint infection after total joint replacement surgery: a retrospective study with a 1-year follow-up [PDF]
Summary: Background: Cephalosporins are recommended as first-line antibiotic prophylaxis in total joint replacement surgery. Studies have shown an increased risk for periprosthetic joint infection (PJI) when non-cephalosporin antibiotics have been used.
Meeri Honkanen+4 more
doaj +2 more sources
Cefuroxime - a new cephalosporin antibiotic.
Cefuroxime is a new broad spectrum cephalosporin antibiotic for administration by injection. It is stable to most beta-lactamases. It is active against gram-positive organisms, including penicillinase-producing staphylococci, and has wide activity against gram-negative bacilli including Enterobacter and many strains of indole-positive Proteus spp.
C. O'callaghan+4 more
semanticscholar +6 more sources
In-Silico discovery of novel cephalosporin antibiotic conformers via ligand-based pharmacophore modelling and de novo molecular design [PDF]
Antibiotic resistance poses a significant global challenge as bacteria evolve in response to antibiotic use, leading to prolonged hospitalizations, increased healthcare costs, and higher mortality rates. Cephalosporins, a class of beta-lactam antibiotics,
Rayhan Chowdhury+7 more
doaj +2 more sources
Second generation cephalosporin antibiotic prophylaxis and Clostridium difficile infection in hip and knee arthroplasty. [PDF]
Al-Tawil K+3 more
europepmc +2 more sources
Antibacterial Activity of Cefamandole, a New Cephalosporin Antibiotic, Compared with that of Cephaloridine, Cephalothin, and Cephalexin [PDF]
S. Eykyn+3 more
semanticscholar +2 more sources
Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic
P. Gower, C. Dash
semanticscholar +2 more sources
Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department [PDF]
J. Borde+6 more
semanticscholar +2 more sources
In Vitro Activity and Pharmacokinetics in Patients of Cefamandole, a New Cephalosporin Antibiotic
N. Shemonsky, J. Carrizosa, M. Levison
semanticscholar +2 more sources
Metabolic Fate of [14C]Cefamandole, a Parenteral Cephalosporin Antibiotic, in Rats and Dogs
H. Sullivan+4 more
semanticscholar +2 more sources